Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Triolo

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Current Opinion in Rheumatology|November 25, 2015
Subclinical gut inflammation in ankylosing spondylitisFrancesco Ciccia, Aroldo Rizzo, Giovanni Triolo
Current Opinion in Rheumatology|May 24, 2016
Intestinal dysbiosis and innate immune responses in axial spondyloarthritisFrancesco Ciccia, Angelo Ferrante, Giovanni Triolo
Annals of the Rheumatic Diseases|August 22, 2014
Response to: 'IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis' by Neerinckx et alFrancesco Ciccia, Riccardo Alessandro, Giovanni Triolo
The New England Journal of Medicine|May 26, 2017
Psoriatic ArthritisFrancesco Ciccia, Giovanni Triolo, Aroldo Rizzo
Best Practice & Research. Clinical Rheumatology|December 15, 2016
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseasesFrancesco Ciccia, Angelo Ferrante, Giuliana Guggino, et al.
Annals of the Rheumatic Diseases|June 28, 2017
Response to: 'Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries' by Graver <i>et al</i>Francesco Ciccia, Aroldo Rizzo, Carlo Salvarani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
ReplyFrancesco Ciccia, Giuliana Guggino, Stefania Raimondo, et al.
Current Opinion in Rheumatology|December 14, 2005
New approaches in the treatment of Adamantiades-Behçet's diseaseNicolò Pipitone, Ignazio Olivieri, Fabrizio Cantini, et al.
Annals of the Rheumatic Diseases|August 25, 2016
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitisFrancesco Ciccia, Aroldo Rizzo, Giuliana Guggino, et al.
Rheumatology International|October 28, 2009
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugsAnnarita Giardina, Angelo Ferrante, Francesco Ciccia, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Current Opinion in Rheumatology|November 25, 2015
Subclinical gut inflammation in ankylosing spondylitisFrancesco Ciccia, Aroldo Rizzo, Giovanni Triolo
Current Opinion in Rheumatology|May 24, 2016
Intestinal dysbiosis and innate immune responses in axial spondyloarthritisFrancesco Ciccia, Angelo Ferrante, Giovanni Triolo
Annals of the Rheumatic Diseases|August 22, 2014
Response to: 'IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis' by Neerinckx et alFrancesco Ciccia, Riccardo Alessandro, Giovanni Triolo
The New England Journal of Medicine|May 26, 2017
Psoriatic ArthritisFrancesco Ciccia, Giovanni Triolo, Aroldo Rizzo
Best Practice & Research. Clinical Rheumatology|December 15, 2016
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseasesFrancesco Ciccia, Angelo Ferrante, Giuliana Guggino, et al.
Annals of the Rheumatic Diseases|June 28, 2017
Response to: 'Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries' by Graver <i>et al</i>Francesco Ciccia, Aroldo Rizzo, Carlo Salvarani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
ReplyFrancesco Ciccia, Giuliana Guggino, Stefania Raimondo, et al.
Current Opinion in Rheumatology|December 14, 2005
New approaches in the treatment of Adamantiades-Behçet's diseaseNicolò Pipitone, Ignazio Olivieri, Fabrizio Cantini, et al.
Annals of the Rheumatic Diseases|August 25, 2016
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitisFrancesco Ciccia, Aroldo Rizzo, Giuliana Guggino, et al.
Rheumatology International|October 28, 2009
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugsAnnarita Giardina, Angelo Ferrante, Francesco Ciccia, et al.
Pageof 10